Inhibition of the adenosine diphosphate receptor P2Y12 reduces atherosclerotic plaque size in hypercholesterolemic ApoE-/- mice

被引：0
|
作者：
Schirmer, S. H. [1 ]
Kratz, M. T. [1 ]
Kazakov, A. [1 ]
Nylander, S. [2 ]
Baumhaekel, M. [1 ]
Laufs, U. [1 ]
Boehm, M. [1 ]
机构：
[1] Saarland Univ Hosp, Homburg, Germany
[2] AstraZeneca R&D, Molndal, Sweden
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [21] Loss of the nutrient receptor Tas1R3 reduces atherosclerotic plaque accumulation and hepatic steatosis in ApoE-/-mice
    Shojaat, Shayla S.
    Engman, Samuel
    Hofferber, Jason
    Keomanivong, Faithe
    Wauson, Eric M.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2020, 76 (04) : 623 - 636
  • [22] Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of Apoe-/- mice
    Thorp, Edward
    Cui, Dongying
    Schrijvers, Dorien M.
    Kuriakose, George
    Tabas, Ira
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (08) : 1421 - 1428
  • [23] Tacrolimus reduces atherosclerotic plaque formation in ApoE-/- mice by inhibiting NLRP3 inflammatory corpuscles
    Li, Xiao
    Shang, Xingfu
    Sun, Lu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (02) : 1393 - 1399
  • [24] Monitoring platelet inhibition induced by P2Y12 receptor blockade:: A comparison of P2Y12 specific assays
    Angiolillo, Domiaick J.
    Desai, Bhaloo
    Hang, Yuan
    Charlton, Ronald
    Bernardo, Esther
    Shoemaker, Steven
    Zenni, Martin
    Guzman, Luis
    Gilmore, Paul
    Bass, Theodore A.
    Costa, Marco A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 205M - 206M
  • [25] A Collagen-Derived Oligopeptide from Salmo salar Collagen Hydrolysates Restrains Atherogenesis in ApoE-/- Mice via Targeting P2Y12 Receptor
    Yang, Yijie
    Liu, Hui
    Cui, Liyuan
    Liu, Yibo
    Fu, Lulu
    Li, Bo
    MOLECULAR NUTRITION & FOOD RESEARCH, 2022, 66 (13)
  • [26] Impact of genetic polymorphisms in the clinical response of oral inhibitors of the platelet P2Y12 adenosine diphosphate (ADP) receptor
    Simon, T.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2010, 59 : S90 - S94
  • [27] Platelet Adenosine Diphosphate P2Y12 Receptor Antagonism: Benefits and Limitations of Current Treatment Strategies and Future Directions
    Angiolillo, Dominick J.
    Ferreiro, Jose Luis
    REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (01): : 60 - 76
  • [28] Congenital severe deficiency or pharmacological inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2
    Scavone, M.
    Femia, E. A.
    Caroppo, V
    Cattaneo, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 100 - 100
  • [29] Usefulness of the INNOVANCE® PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y12 receptor for adenosine diphosphate
    Scavone, Mariangela
    Germanovich, Ksenia
    Femia, Eti A.
    Cattaneo, Marco
    THROMBOSIS RESEARCH, 2014, 133 (02) : 254 - 256
  • [30] Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE-/- mice
    Knutsson, Anki
    Hsiung, Sabrina
    Celik, Selvi
    Rattik, Sara
    Mattisson, Ingrid Yao
    Wigren, Maria
    Scher, Howard I.
    Nilsson, Jan
    Hultgardh-Nilsson, Anna
    SCIENTIFIC REPORTS, 2016, 6
12345